Imunon, Inc. CLSN
Set alert
1.95 +1.95 —
Day range unavailable
52-week range unavailable
- Open
- —
- Prev close
- 0.00
- Mkt cap
- 14.47M
- Vol
- 0
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- —
- High
- —
- Forward P/E
- -0.52
- Beta
- 2.26
- Short ratio
- 0.72
- Inst. own
- 15.56%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Aug 15, 2022
- 50-d avg
- 2.20
- 200-d avg
- 2.52
- 1y target
- 27.00
Analyst view
Consensus: buy
Buy
Price target (mean) 27.00 +1287.0% upside
Now 1.95
- Target (low)
- 16.00
- Target (mean)
- 27.00
- Target (high)
- 45.00
Ratings (0m) 2 2 buy · 0 hold · 0 sell
- Strong buy1
- Buy1
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 2
- 1 month ago 2
- 2 months ago 3
- 3 months ago 3
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.81 | -0.85 – -0.77 | -0.90 | +10.0% | 100.00K | -20.0% | 2 |
| Next quarter | -0.83 | -0.86 – -0.80 | -3.62 | +77.1% | 100.00K | -20.0% | 2 |
| Current year | -4.14 | -4.25 – -4.03 | -3.78 | -9.5% | 500.00K | 0.0% | 2 |
| Next year | -3.78 | -4.32 – -3.25 | -4.14 | +8.7% | 250.00K | -50.0% | 2 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Apr 13, 2022 | HC Wainwright & Co. | Initiated | — | Buy |
| Nov 22, 2017 | Oppenheimer | Initiated | — | Outperform |
| Oct 5, 2017 | Maxim Group | Upgrade | Hold | Buy |
| Jul 15, 2015 | Maxim Group | Initiated | — | Buy |
| Jul 13, 2015 | BTIG Research | Initiated | — | Buy |
| Sep 30, 2013 | H.C. Wainwright | Initiated | — | Buy |
| Jan 31, 2013 | Roth Capital | Downgrade | Buy | Neutral |
| Jan 17, 2013 | Brean Capital | Downgrade | Buy | Sell |
| Nov 27, 2012 | Dawson James | Initiated | — | Market Outperform |